Literature DB >> 3485395

Bronchoalveolar lavage fluid evaluation in rheumatoid arthritis.

J G Garcia, N Parhami, D Killam, P L Garcia, B A Keogh.   

Abstract

Rheumatoid arthritis (RA), a systemic disorder of unknown cause, is associated with a variety of well-recognized pulmonary abnormalities including interstitial lung disease. To investigate possible pathogenic events in this disorder, we performed bronchoalveolar lavage (BAL) in 24 patients with classic or definite RA. Using radiographic and physiologic parameters as well as BAL cell differentials, 3 distinct groups emerged. Group I consisted of 9 patients with evidence of clinical interstitial lung involvement. Group II consisted of 5 patients without evidence of clinical interstitial lung disease (normal chest roentgenogram and functional testing) but who had abnormal BAL cellular differentials. The 10 remaining patients (Group III) had no evidence of clinical interstitial lung disease and had normal BAL cell differentials. Bronchoalveolar lavage in Group I had a significantly increased percentage of neutrophils (12.4 +/- 4.2; p less than 0.05) compared with Group II (2.4 +/- 0.8) and Group III (2.9 +/- 0.6). All patients in Group II had elevated BAL lymphocytes (24.4 +/- 6.4) compared with Group I (10.1 +/- 3.8; p greater than 0.05) and Group III (5.4 +/- 0.7; p less than 0.01). Both Groups I and II had detectable IgM in BAL (0.02 +/- 0.01 and 0.04 +/- 0.02 mg/mg of albumin, respectively), whereas Group III patients and normal control subjects did not (p less than 0.01). There was a marked reduction in BAL T-lymphocyte Leu 3/Leu 2A (helper/suppressor) cell ratios in Group I (0.92 +/- 0.02; p less than 0.05) compared with Group II (2.6 +/- 0.6) and Group III (1.6 +/- 0.1).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485395     DOI: 10.1164/arrd.1986.133.3.450

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  21 in total

Review 1.  Subclinical alveolitis in immunologic systemic disorders.

Authors:  B Wallaert
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis.

Authors:  A Schnabel; C Richter; S Bauerfeind; W L Gross
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 3.  The many uses of bronchoalveolar lavage.

Authors:  H M Morrison; R A Stockley
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-25

4.  Bronchoalveolar lavage in rheumatoid arthritis and secondary Sjögren's syndrome.

Authors:  W Popp; L Ritschka; O Scherak; O Braun; G Kolarz; H Rauscher; H Zwick
Journal:  Lung       Date:  1990       Impact factor: 2.584

5.  Bronchoalveolar lavage in patients with mild and severe rheumatoid lung disease.

Authors:  D M Gilligan; C M O'Connor; K Ward; D Moloney; B Bresnihan; M X FitzGerald
Journal:  Thorax       Date:  1990-08       Impact factor: 9.139

6.  Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis.

Authors:  J Biederer; A Schnabel; C Muhle; W L Gross; M Heller; M Reuter
Journal:  Eur Radiol       Date:  2003-10-14       Impact factor: 5.315

7.  Pericardial and pulmonary involvement in rheumatoid arthritis in Turkey.

Authors:  N Imeryüz; H Yazici; H Koçak; M Erk; A Ozder; S M Karcier; M Ozkan; G Ongen; S Yurdakul; H Ozdoğan
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

8.  Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases.

Authors:  B Wallaert; F Bart; C Aerts; A Ouaissi; P Y Hatron; A B Tonnel; C Voisin
Journal:  Thorax       Date:  1988-01       Impact factor: 9.139

Review 9.  Insights into the study and origin of the citrullinome in rheumatoid arthritis.

Authors:  Justyna Fert-Bober; Erika Darrah; Felipe Andrade
Journal:  Immunol Rev       Date:  2019-12-25       Impact factor: 12.988

10.  Neutrophilic Alveolitis and High Serum Pro-Brain Natriuretic Peptide Level may be Indicators of Pulmonary Functional Impairment in Connective Tissue Disorders.

Authors:  Serap Unculu; Özlem Erçen Diken; Aydın Çiledağ; Aydan Ikincioğullari; Demet Karnak; Oya Kayacan; Murat Turgay
Journal:  Arch Rheumatol       Date:  2015-08-31       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.